Olatuton (Octreotide Acetate)

Octreotide Acetate, the active ingredient in Olatuton, is a peptide hormone presented as a formulation for injection use. It regulates hormone secretion and is employed in the management of specific endocrine‑related conditions in adults. GNH USA supplies Olatuton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Olatuton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Olatuton is a synthetic peptide that modulates neuroendocrine pathways and is indicated for several clinical conditions.

- Acromegaly: Reduces excessive growth hormone secretion and associated tissue overgrowth. - Carcinoid syndrome: Controls flushing and diarrhoea associated with serotonin‑secreting tumours. - VIPoma (VIP‑related diarrhoea): t     

Octable